12 nov: Selskabsmeddelelse nr. 11/2018 - Paul Marcun tiltræder Coloplast ..
12 nov: Delårsrapport for 3. kvartal 2018 - SP Group A/S
12-11-2018 07:57:26

Paul Marcun returns to Coloplast as a member of the Executive Management team and new Executive Vice President of Chronic Care

Relateret indhold
11 jan - 
Fredagens aktier: Ambu endte i toppen i svagt negativt ..
11 jan - 
Aktier/middag: Danske Bank klarer skærene i afdæmpet ma..
11 jan - 
Aktier/åbning: William Demant topper i grøn fredagsstar..
Relateret debat
29 dec - 
@nohope Der har vaeret tale om to former for afstemning..
29 dec - 
En oldefar der i en periode har været medlem af DNSAP e..
29 dec - 
@tommycarstensen Tak for dine svar. Jeg har arbejdet me..

Paul Marcun will join Coloplast’s Executive Management team as Executive Vice President, Chronic Care in mid-January 2019. He will take over from Kristian Villumsen who, as of December 4th, will assume the role as President and CEO of Coloplast.

As Executive Vice President of Chronic Care, Paul Marcun will be responsible for Global Marketing, the sales regions and the innovation pipeline within Ostomy Care and Continence Care.

  • I am very happy to be able to welcome Paul Marcun back to Coloplast. This time as Executive Vice President of Chronic Care and as a member of the company’s Executive Management. Paul is a strong leader and an accomplished business developer, and with him at the helm of Chronic Care, Coloplast is well-equipped for the future, says CEO Lars Rasmussen, Coloplast.

Following Paul’s appointment, Coloplast’s Executive Management team will consist of four members as of mid-January 2019: Kristian Villumsen, President & CEO, Anders Lonning-Skovgaard, EVP & CFO, Allan Rasmussen, EVP Global Operations and Paul Marcun, EVP Chronic Care. 

  • I look forward to welcoming Paul back to Coloplast in a new role, and I know his former team feels the same way. Paul brings extensive sales and executive leadership experience to the role, and he knows our company and culture well, says Kristian Villumsen, Coloplast.

New leader in Chronic Care

Paul Marcun has around 20 years of experience in the medtech industry. Paul first joined Coloplast in 2015 and he has been part of Coloplast A/S’ management team for more than three years as Senior Vice President, Emerging Markets. Prior to joining Coloplast A/S, Paul served as President Eastern Europe, Middle East, Africa & India at Stryker International and Vice President Ortho-Clinical Diagnostics and Vice President Ethicon Endo Surgery & Advanced Sterilization Products at Johnson & Johnson. Paul Marcun recently served as President of Surgical Workflows at Getinge.

Paul holds a Bachelor of Veterinary Science (Hons.) from the University of Melbourne and a Master of Business Administration from the University of Technology in Sydney. Paul is an Australian and British citizen and was born in 1966. 

CONTACTS

Lina Danstrup

Senior Media Relations Manager, Corporate Communication

+45 49 11 26 07

dklina@coloplast.com

Ellen Bjurgert

Vice President, Investor Relations

+45 49 11 33 76

dkebj@coloplast.com

Attachment

logo.png

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Analytiker: Højere DSV-kurs kan holde konkurrenter fra Panalpina-citat

18-01-2019 13:59:53
Der har været god gænge i DSV-aktien, siden at det onsdag kom frem, at transportgiganten har lagt et bud på den schweiziske konkurrent Panalpina.Kursen er nu 9 pct. højere end før buddet, og det øger chancen for, at DSV løber med selskabet. Sådan lyder det ifølge Jyllands-Posten Finans fra Nordea i en analyse.DSV har nemlig tilbudt både kontantbetaling og DSV-aktier for selskabet - og med den stig..

Jyske Bank mister troen på Pandora

18-01-2019 09:54:35
Jyske Bank ser et mindre potentiale i Pandora efter et svagt julesalg. Banken skærer kursmålet med en fjerdedel, så det nu lyder på 300 kr.Torsdag kom der tal fra den amerikanske smykkekæde Signet Jewels, og heraf fremgik det specifikt, at julesalget af Pandora-smykker fra smykkekoncernens amerikanske forhandlere, Jared, var faldet. Julesalget omfatter både november, december og den første uge af ..

Aktier/tendens: Bavarian kommer med godt nyt i positivt marked

18-01-2019 08:32:42
Godt nyt fra Bavarian Nordic kan fredag give aktien en hovedrolle i et i øvrigt positivt marked, hvor investorerne glæder sig over signaler om en kommende løsning på handelskonflikten mellem USA og Kina.De amerikanske aktier steg ganske pænt torsdag, efter at Wall Street Journal skrev, at USA's finansminister, Steven Mnuchin, på interne strategimøder har foreslået, at USA skal rulle den nyindførte..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Aktier/tendens: Bavarian kommer med godt nyt i positivt marked
2
Demokrater raser efter nye beskyldninger mod Trump
3
Zealand/Kempen: Ser kurspotentiale på 70 pct. - GENT
4
Bavarian: Den amerikanske regering udnytter 44 mio. dollar-option
5
USA overvejer at rulle Kina-told tilbage - GENT

Relaterede aktiekurser

Coloplast B A/S 615,40 0,9% Stigning i aktiekurs

Køb- og salgssignaler

  • Trend
  • Pengemaskinen

Copyright Berlingske Media 2019  Handelsbetingelser  |  Cookiedeklaration  |  Cookie- og Privatlivspolitik  |  Ophavsret og vilkår
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
18. januar 2019 16:40:53
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20190108.3 - EUROWEB2 - 2019-01-18 16:40:53 - 2019-01-18 16:40:53 - 1 - Website: OKAY